ImmunoPrecise Antibodies Ltd. Files 6-K Report
Ticker: HYFT · Form: 6-K · Filed: Jan 3, 2025 · CIK: 1715925
Sentiment: neutral
Topics: disclosure, regulatory-filing, material-change-report
TL;DR
IPA files 6-K, referencing a Jan 2 material change report. Standard disclosure.
AI Summary
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on January 3, 2025, incorporating by reference a Material Change Report dated January 2, 2025. This filing is related to their existing Registration Statements on Form F-3 and Form S-8.
Why It Matters
This filing indicates ongoing reporting and potential updates related to ImmunoPrecise Antibodies Ltd.'s securities, which could affect investors tracking the company's regulatory compliance and disclosures.
Risk Assessment
Risk Level: low — This is a routine filing (Form 6-K) that incorporates a material change report, indicating standard disclosure practices rather than a specific event with immediate high risk.
Key Players & Entities
- ImmunoPrecise Antibodies Ltd. (company) — Filer of the Form 6-K
- January 2, 2025 (date) — Date of the Material Change Report
- January 3, 2025 (date) — Filing date of the Form 6-K
- Form F-3 (document) — Registration statement incorporated by reference
- Form S-8 (document) — Registration statement incorporated by reference
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is a Report of Foreign Private Issuer filed for the month of January 2025, and it incorporates by reference a Material Change Report dated January 2, 2025.
What is the filing date of this report?
The filing date of this Form 6-K is January 3, 2025.
Which registration statements are referenced in this filing?
Exhibit 99.1 of this Form 6-K is incorporated by reference into Registration Statements on Form F-3 (File Nos. 333-273197 and 333-281312) and Registration Statement on Form S-8 (File No. 333-256730).
What is the company's principal executive office address?
The company's principal executive office is located at 3204 - 4464 Markham Street, Victoria, British Columbia V8Z 7X8.
What type of company is ImmunoPrecise Antibodies Ltd. based on its SIC code?
ImmunoPrecise Antibodies Ltd. is classified under Pharmaceutical Preparations (SIC code 2834).
Filing Stats: 197 words · 1 min read · ~1 pages · Grade level 10.7 · Accepted 2025-01-03 10:20:55
Filing Documents
- form6k.htm (6-K) — 6KB
- exhibit99-1.htm (EX-99.1) — 14KB
- 0001062993-25-000052.txt ( ) — 21KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IMMUNOPRECISE ANTIBODIES LTD. Date: January 3, 2025 By: /s/ Jennifer Bath Name: Jennifer Bath Title: President and Chief Executive Officer